Candel shareholders elect four Class II directors, ratify KPMG as auditor at June 23 annual meeting

Candel Therapeutics, Inc.

Elected Edward J. Benz, Paul B. Manning, Maha Radhakrishnan, and Paul Peter Tak as Class II directors for three-year terms.
Director voting: Benz received 24.9M for, 6.8M withheld; Manning 31.6M for, 102k withheld; Radhakrishnan 31.0M for, 646k withheld; Tak 31.4M for, 279k withheld.
KPMG LLP ratified as independent auditor for FY 2026 with 53.5M for, 238k against, 88k abstain.
All proposals passed; no other matters were voted on at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.